Publications
Publications 4551 - 4575 de 33557
| Titre | DOI |
|---|---|
|
Board recruitment as a strategic answer: Do companies' strategies for innovation influence the selection of new board members? E. Zenou; I. Allemand; B. Brullebaut; F. Galia 2020 |
10.1002/jsc.2316 |
|
Boceprevir-PegIFN-RBV tritherapy in treatment-experienced HCV genotype 1-HIV co-infected patients: response rate at W48 (ANRS-HC27 BocepreVIH Study) C. Fougerou-Leurent; I. Poizot-Martin; E. Teicher; E. Rosenthal; L. Alric; L. Piroth; M. Bourliere; D. Guyader; J.M. Molina; E. Bellissant 2014 |
|
|
Boceprevir-PegIFN-RBV tritherapy in treatment-experienced HCV genotype 1-HIV co-infected patients: response rate at W48 (ANRS-HC27 BocepreVIH Study) C. Fougerou-Leurent; I. Poizot-Martin; E. Teicher; E. Rosenthal; L. Alric; L. Piroth; M. Bourliere; D. Guyader; J.M. Molina; E. Bellissant 2014 |
|
|
BODIPY atropisomer interconversion, face discrimination, and superstructure appending P.E. Doulain; C. Goze; E. Bodio; P. Richard; R.A. Decreau 2016 |
10.1039/c5cc10526a |
|
BODIPY-diketopyrrolopyrrole-porphyrin conjugate small molecules for use in bulk heterojunction solar cells L. Bucher; N. Desbois; E.N. Koukaras; C.H. Devillers; S. Biswas; G.D. Sharma; C.P. Gros 2018 |
10.1039/c8ta01291a |
|
BODIPY: A Highly Versatile Platform for the Design of Bimodal Imaging Probes D. Lhenry; M. Larrouy; C. Bernhard; V. Goncalves; O. Raguin; P. Provent; M. Moreau; B. Collin; A. Oudot; J.M. Vrigneaud; F. Brunotte; C. Goze; F. Denat 2015 |
10.1002/chem.201501676 |
|
BODIPY: a highly versatile platform for the design of MonoMolecular Multimodal Imaging Probes C. Goze; M. Ipuy; N. Maindron; D. Lhenry; C. Bernhard; M. Moreau; P. Provent; A. Oudot; B. Collin; J. Vrigneaud; F. Brunotte; F. Denat 2016 |
|
|
BODIPY: a highly versatile platform for the design of MonoMolecular Multimodal Imaging Probes C. Goze; M. Ipuy; N. Maindron; D. Lhenry; C. Bernhard; M. Moreau; P. Provent; A. Oudot; B. Collin; J. Vrigneaud; F. Brunotte; F. Denat 2016 |
|
|
BODIPYS and aza-BODIPY derivatives as promising fluorophores for in vivo molecular imaging and theranostic applications E. Bodio; F. Denat; C. Goze 2019 |
10.1142/S1088424619501268 |
|
Body and soul: Do children distinguish between foods when generalizing biological and psychological properties? J.P. Thibaut; S.P. Nguyen; G.L. Murphy 2016 |
10.1080/10409289.2016.1146551 |
|
Body Composition and Fat Distribution in Patients with Psoriasis or Psoriatic Arthritis E. Toussirot; F. Aubin; M. Desmarets; D. Wendling; B. Auge; J. Gillard; O. Messica; X. Guillot; C. Laheurte; E. Monnet; G. Dumoulin 2019 |
|
|
Body Composition and Fat Distribution in Patients with Psoriasis or Psoriatic Arthritis E. Toussirot; F. Aubin; M. Desmarets; D. Wendling; B. Auge; J. Gillard; O. Messica; X. Guillot; C. Laheurte; E. Monnet; G. Dumoulin 2019 |
|
|
Body composition and fat distribution in patients with psoriasis or psoriatic arthritis E. Toussirot; F. Aubin; M. Desmarets; D. Wendling; B. Auge; J. Gillard; O. Messica; X. Guillot; C. Laheurte; E. Monnet; G. Dumoulin 2021 |
|
|
BODY COMPOSITION AND FAT DISTRIBUTION IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS. E. Toussirot; F. Aubin; M. Desmarets; D. Wendling; B. Auge; J. Gillard; O. Messica; X. Guillot; C. Laheurte; E. Monnet; G. Dumoulin 2020 |
10.1136/annrheumdis-2020-eular.2611 |
|
Body Fat Distribution and Adipokine Secretion Are Not Associated with Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus D. Dossarps; J.M. Petit; B. Guiu; J.P. Cercueil; L. Duvillard; A.M. Bron; C. Creuzot-Garcher 2014 |
10.1159/000355323 |
|
Body interventional procedures: which is the best method for CT guidance? J.P. Lustig; S. Aubry; C. Vidal; L. Pazart; A. Moreau-Gaudry; I. Bricault 2020 |
10.1007/s00330-019-06490-4 |
|
Body interventional procedures: which is the best method for CT guidance? J.P. Lustig; S. Aubry; C. Vidal; L. Pazart; A. Moreau-Gaudry; I. Bricault 2020 |
10.1007/s00330-019-06490-4, Early Access Date = {NOV 2019 |
|
Body Mass Index and Age Do Not Influence Survival in Patients with Lung Cancers Treated with PD1/PDL1 Immune Checkpoint Inhibitors C. Richard; A. Elkrief; J. Malo; L. Cvetkovic; M. Florescu; N. Blais; M. Tehfe; A. Gagne; C. Labbe; M. Orain; P. Joubert; F. Ghiringhelli; B. Routy 2019 |
10.1016/j.jtho.2019.08.904 |
|
Body mass index trajectories and functional decline in older adults: Three-City Dijon cohort study F. Artaud; A. Singh-Manoux; A. Dugravot; B. Tavernier; C. Tzourio; A. Elbaz 2016 |
10.1007/s10654-015-0027-4 |
|
Body Odor and Perfume of Caregivers are Salient to Typically- and Atypically- Developing Young Children K. Durand; B. Schaal; G. Zucco 2015 |
|
|
Body Odor and Perfume of Caregivers are Salient to Typically- and Atypically- Developing Young Children K. Durand; B. Schaal; G. Zucco 2015 |
|
|
Boiling sheep liver or lung for 30 minutes is necessary and sufficient to kill Echinococcus granulosus protoscoleces in hydatid cysts J. Li; C. Wu; H. Wang; H. Liu; D.A. Vuitton; H. Wen; W. Zhang 2014 |
10.1051/parasite/2014064 |
|
Boldness-exploration behavioral syndrome: interfamily variability and repeatability of personality traits in the young of the convict cichlid (Amatitlania siquia) G.P.F. Mazue; F.X. Dechaume-Moncharmont; J.G.J. Godin 2015 |
10.1093/beheco/arv030 |
|
BOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS (EVE) IN COMBINATION WITH LETROZOLE (LET) IN POSTMENOPAUSAL PATIENTS (PTS) WITH ESTROGEN RECEPTORPOSITIVE (ER plus ), HUMAN EPIDE T. Bachelot; C. Villanueva; M. Royce; M. Debled; F.Melo Cruz; R. Hegg; T. Brechenmacher; C. Manlius; F. Ringeisen; F. Cardoso 2015 |
10.1016/S0960-9776(15)30068-0 |
|
BOLERO-4: Phase 2 trial of first-line everolimus (EVE) plus letrozole (LET) in estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (BC) M. Royce; C. Villanueva; M. Ozguroglu; T. Bachelot; S. Azevedo; M. Cruz; R. Hegg; M. Debled; W.J. Gradishar; C. Manlius; A. Ridolfi; J. Lin; F. Ringeisen; F. Cardoso 2016 |
10.1093/annonc/mdw365.1 |